Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
148.51
+0.29 (0.20%)
Jun 29, 2026, 9:40 AM EDT - Market open

Palvella Therapeutics Stock Forecast

Stock Price Forecast

The 13 analysts with 12-month price forecasts for Palvella Therapeutics stock have an average target of 230.62, with a low estimate of 205 and a high estimate of 270. The average target predicts an increase of 55.29% from the current stock price of 148.51.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $205 $230.62 $225 $270
Change +38.04% +55.29% +51.51% +81.81%

Analyst Ratings

The average analyst rating for Palvella Therapeutics stock from 15 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy 151515151615
Buy 000000
Hold 000000
Sell 000000
Strong Sell 000000
Total 151515151615

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Canaccord Genuity
Canaccord Genuity
Buy
Reiterates
$227
Buy Reiterates $227 +52.86% Jun 25, 2026
Stifel Nicolaus
Stifel Nicolaus
Buy
Reiterates
$250
Buy Reiterates $250 +68.34% Jun 24, 2026
Craig-Hallum
Craig-Hallum
Buy
Reiterates
$205
Buy Reiterates $205 +38.04% Jun 22, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Maintains
$255$270
Buy Maintains $255$270 +81.81% Jun 11, 2026
Mizuho Securities
Mizuho Securities
Buy
Reiterates
$240
Buy Reiterates $240 +61.61% Jun 4, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
33.86M
EPS This Year
-5.57
from -3.71
EPS Next Year
-6.82
from -5.57
Fiscal Year FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027 FY 2028
Period Ending Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027 Dec 31, 2028
Revenue
-----33.86M142.26M
Revenue Growth
------320.18%
EPS
-4.822.17-7.83-3.71-5.68-6.90-3.16
EPS Growth
-------
Forward PE
-------
No. Analysts ----141310
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202620272028
High n/a 73.7M
Avg n/a 33.9M
Low n/a 11.0M

Revenue Growth

Revenue Growth 20272028
High -
995.5%
Avg -
320.2%
Low -
124.5%

EPS Forecast

EPS 202620272028
High -3.45 -1.54
Avg -5.57 -6.82
Low -6.91 -11.16

EPS Growth

EPS Growth 202620272028
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.